Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing oxprenolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxprenolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxprenolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxprenolol hydrochloride 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxprenolol hydrochloride 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxprenolol hydrochloride 160mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxprenolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxprenolol hydrochloride 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxprenolol hydrochloride 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxprenolol hydrochloride (substance) |
Inferred relationship |
Some |
1 |